PEDIATRICS Vol. 89 No. 5 May 1992, pp. 809-818
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, T. B.
Right arrow Articles by Maisels, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, T. B.
Right arrow Articles by Maisels, M. J.

Evaluation and Treatment of Jaundice in the Term Newborn: A Kinder, Gentler Approach

Thomas B. Newman MD, MPH1 and M. Jeffrey Maisels MB, BCh2

1 From the Departments of Pediatrics and Epidemiology and Biostatistics and the Robert Wood Johnson Clinical Scholars Program, School of Medicine, University of California, San Francisco
2 From the Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI

Standard recommendations for evaluating and treating jaundice in term babies include following all babies closely for jaundice, obtaining several laboratory tests in those with early jaundice or bilirubin levels more than 12 to 13 mg/dL (205 to 222 µmol/L), using phototherapy to try to keep bilirubin levels below 20 mg/dL (342 µmol/L), and doing exchange transfusions if phototherapy fails, regardless of the cause of the jaundice. These recommendations are likely to lead to unnecessary testing and treatment of many jaundiced term infants. Because most jaundiced infants have no underlying illness, and the generally recommended laboratory tests lack sensitivity and specificity, they are seldom useful. In most babies, the only blood tests needed to evaluate jaundice are the blood type and group (of baby and mother) and a direct Coombs' test. A determination of direct bilirubin level should be added if jaundice is prolonged (>2 to 4 weeks) or the baby has other signs of illness. Bilirubin toxicity is rare in term babies without hemolysis. In this low-risk group, the risks and cost of identifying and treating high bilirubin levels may exceed the benefits. Such infants need not be closely followed for jaundice. If significant jaundice is nonetheless found, treatment should be deferred to relatively high levels of serum bilirubin, with a goal of keeping bilirubin levels below 400 to 500 µmol/L (23.4 to 29.2 mg/dL). Babies with hemolytic disease should be followed more closely, and their bilirubin levels kept below 300 to 400 µmol/L (17.5 to 23.4 mg/dL). These recommendations should be reevaluated as new data become available. In the meantime, currently available data justify an approach to the jaundiced term infant that is less aggressive than previously recommended.

Key Words: jaundice • bilirubin level • phototherapy • exchange transfusion • newborn

Submitted on August 2, 1991
Accepted on November 12, 1991




This article has been cited by other articles:


Home page
 Ann Clin BiochemHome page
J. M Kirk
Neonatal jaundice: a critical review of the role and practice of bilirubin analysis
Ann Clin Biochem, September 1, 2008; 45(5): 452 - 462.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. E. Burgos, S. K. Schmitt, D. K. Stevenson, and C. S. Phibbs
Readmission for Neonatal Jaundice in California, 1991-2000: Trends and Implications
Pediatrics, April 1, 2008; 121(4): e864 - e869.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
K. Ives
Preventing kernicterus: a wake-up call
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F330 - F331.
[Full Text] [PDF]

Home page
 PediatricsHome page
L. A. Steiner, M. J. Bizzarro, R. A. Ehrenkranz, and P. G. Gallagher
A Decline in the Frequency of Neonatal Exchange Transfusions and Its Effect on Exchange-Related Morbidity and Mortality
Pediatrics, July 1, 2007; 120(1): 27 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
M. Gomez, C. Bielza, J. A. Fernandez del Pozo, and S. Rios-Insua
A Graphical Decision-Theoretic Model for Neonatal Jaundice
Med Decis Making, May 1, 2007; 27(3): 250 - 265.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
W.-X. Chen, V. C. N. Wong, and K.-Y. Wong
Neurodevelopmental Outcome of Severe Neonatal Hemolytic Hyperbilirubinemia
J Child Neurol, June 1, 2006; 21(6): 474 - 479.
[Abstract] [PDF]

Home page
 PediatricsHome page
L. D. Eggert, S. E. Wiedmeier, J. Wilson, and R. D. Christensen
The Effect of Instituting a Prehospital-Discharge Newborn Bilirubin Screening Program in an 18-Hospital Health System
Pediatrics, May 1, 2006; 117(5): e855 - e862.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
V. Wong, W.-X. Chen, and K.-Y. Wong
Short- and Long-Term Outcome of Severe Neonatal Nonhemolytic Hyperbilirubinemia
J Child Neurol, April 1, 2006; 21(4): 309 - 315.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
W.-X. Chen and V. Wong
Visual Evoked Potentials in Neonatal Hyperbilirubinemia
J Child Neurol, January 1, 2006; 21(1): 58 - 62.
[Abstract] [PDF]

Home page
 NeoReviewsHome page
J. C. Martinez
Argentinean Perspective of the 2004 AAP Hyperbilirubinemia Guidelines
NeoReviews, January 1, 2006; 7(1): e4 - e6.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
D Manning
American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2005; 90(6): F450 - F451.
[Full Text] [PDF]

Home page
 PediatricsHome page
J. F. Watchko
Vigintiphobia Revisited
Pediatrics, June 1, 2005; 115(6): 1747 - 1753.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
G J Escobar, J D Greene, P Hulac, E Kincannon, K Bischoff, M N Gardner, M A Armstrong, and E K France
Rehospitalisation after birth hospitalisation: patterns among infants of all gestations
Arch. Dis. Child., February 1, 2005; 90(2): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
T. B Newman
The power of stories over statistics
BMJ, December 20, 2003; 327(7429): 1424 - 1427.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
L. Davidson and E. H. Thilo
How to Make Kernicterus a "Never Event"
NeoReviews, November 1, 2003; 4(11): e308 - 314.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
A. Riskin, M. Abend-Weinger, and D. Bader
How Accurate are Neonatologists in Identifying Clinical Jaundice in Newborns?
Clinical Pediatrics, March 1, 2003; 42(2): 153 - 158.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
K. B. Roberts
Urinary Tract Infections in Young Febrile Infants: Is Selective Testing Acceptable?
Arch Pediatr Adolesc Med, January 1, 2002; 156(1): 6 - 7.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
P. R. Hannon, S. K. Willis, and S. C. Scrimshaw
Persistence of Maternal Concerns Surrounding Neonatal Jaundice: An Exploratory Study
Arch Pediatr Adolesc Med, December 1, 2001; 155(12): 1357 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
Y. Yilmaz, S. Degirmenci, F. Akdas, S. Kulekci, A. Ciprut, S. Yuksel, F. Yildiz, L. Karadeniz, and A. Say
Prognostic Value of Auditory Brainstem Response for Neurologic Outcome in Patients With Neonatal Indirect Hyperbilirubinemia
J Child Neurol, October 1, 2001; 16(10): 772 - 775.
[Abstract] [PDF]

Home page
 JAMAHome page
Kernicterus in Full-Term Infants--United States, 1994-1998
JAMA, July 18, 2001; 286(3): 299 - 300.
[Full Text] [PDF]

Home page
 PediatricsHome page
M. C. Harris, J. C. Bernbaum, J. R. Polin, R. Zimmerman, and R. A. Polin
Developmental Follow-Up of Breastfed Term and Near-Term Infants With Marked Hyperbilirubinemia
Pediatrics, May 1, 2001; 107(5): 1075 - 1080.
[Abstract] [Full Text]

Home page
 NEJMHome page
P. A. Dennery, D. S. Seidman, and D. K. Stevenson
Neonatal Hyperbilirubinemia
N. Engl. J. Med., February 22, 2001; 344(8): 581 - 590.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. D. MALKIN, S. GARBER, M. S. BRODER, and E. KEELER
Infant Mortality and Early Postpartum Discharge
Obstet. Gynecol., August 1, 2000; 96(2): 183 - 188.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
V. K. Bhutani, G. R. Gourley, S. Adler, B. Kreamer, C. Dalin, and L. H. Johnson
Noninvasive Measurement of Total Serum Bilirubin in a Multiracial Predischarge Newborn Population to Assess the Risk of Severe Hyperbilirubinemia
Pediatrics, August 1, 2000; 106(2): 17e - 17.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. B. Newman and M. J. Maisels
Less Aggressive Treatment of Neonatal Jaundice and Reports of Kernicterus: Lessons About Practice Guidelines
Pediatrics, January 1, 2000; 105(1): 242 - 245.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. B. Newman, G. J. Escobar, V. M. Gonzales, M. A. Armstrong, M. N. Gardner, and B. F. Folck
Frequency of Neonatal Bilirubin Testing and Hyperbilirubinemia in a Large Health Maintenance Organization
Pediatrics, November 1, 1999; 104(5): 1198 - 1203.
[Abstract] [Full Text]

Home page
 Arch Pediatr Adolesc MedHome page
M. Watkinson
Formula for Jaundiced Breast-fed Infants
Arch Pediatr Adolesc Med, June 1, 1999; 153(6): 657 - 658.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
S. Yigit, M. Yurdakök, K. Kilinç, O. Oran, G. Erdem, and G. Tekinalp
Serum malondialdehyde concentration in babies with hyperbilirubinaemia
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1999; 80(3): 235F - 237.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Dore, M. Takahashi, C. D. Ferris, L. D. Hester, D. Guastella, and S. H. Snyder
Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury
PNAS, March 2, 1999; 96(5): 2445 - 2450.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
V. K. Bhutani, L. Johnson, and E. M. Sivieri
Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns
Pediatrics, January 1, 1999; 103(1): 6 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Hammerman, R. Goldstein, M. Kaplan, M. Eran, D. Goldschmidt, A. I. Eidelman, and L. M. Gartner
Bilirubin in the Premature: Toxic Waste or Natural Defense?
Clin. Chem., December 1, 1998; 44(12): 2551 - 2553.
[Full Text] [PDF]

Home page
 PediatricsHome page
T. Valaes, G. S. Drummond, and A. Kappas
Control of Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Newborns Using an Inhibitor of Bilirubin Production, Sn-Mesoporphyrin
Pediatrics, May 1, 1998; 101 (5): e1 - e1.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
L. F. Nazarian and W. O. Robertson
Personal Reflections on the AAP Practice Parameter on Management of Hyperbilirubinemia in the Healthy Term Newborn
Pediatr. Rev., March 1, 1998; 19(3): 75 - 77.
[Full Text] [PDF]

Home page
 PediatricsHome page
L. M. Gartner, C. T. Herrarias, and R. H. Sebring
Practice Patterns in Neonatal Hyperbilirubinemia
Pediatrics, January 1, 1998; 101(1): 25 - 31.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. J. Madlon-Kay
Recognition of the Presence and Severity of Newborn Jaundice by Parents, Nurses, Physicians, and Icterometer
Pediatrics, September 1, 1997; 100(3): e3 - e3.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. C. Jackson
Adverse Events Associated With Exchange Transfusion in Healthy and Ill Newborns
Pediatrics, May 1, 1997; 99(5): e7 - e7.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Perlman, B. B. Rogers, and D. Burns
Kernicteric Findings at Autopsy in Two Sick Near Term Infants
Pediatrics, April 1, 1997; 99(4): 612 - 612.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Rosenthal
Assessing liver function and hyperbilirubinemia in the newborn
Clin. Chem., January 1, 1997; 43(1): 228 - 234.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
T. W. R. Hansen
Therapeutic Approaches to Neonatal Jaundice: An International Survey
Clinical Pediatrics, June 1, 1996; 35(6): 309 - 316.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
T. W. R. Hansen
Bilirubin in the Brain: Distribution and Effects on Neurophysiological and Neurochemical Processes
Clinical Pediatrics, August 1, 1994; 33(8): 452 - 459.
[PDF]

Home page
 CLIN PEDIATRHome page
T. B. Newman and M. J. Easterling
Yield of Reticulocyte Counts and Blood Smears in Term Infants
Clinical Pediatrics, February 1, 1994; 33(2): 71 - 76.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
J. E. Hodgman and N. Edwards
Racial Differences in Neonatal Jaundice: Hyperbilirubinemia in Hispanic Infants A Survey
Clinical Pediatrics, December 1, 1992; 31(12): 719 - 722.
[PDF]

Home page
 JWatch GeneralHome page
NEW GUIDELINES FOR TREATING JAUNDICED NEONATES
Journal Watch (General), May 26, 1992; 1992(526): 1 - 1.
[Full Text]